BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28148558)

  • 1. Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA-Associated GN.
    Chen Y; Bao H; Liu Z; Liu X; Gao E; Zeng C; Zhang H; Liu Z; Hu W
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):417-425. PubMed ID: 28148558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.
    Bjørneklett R; Sriskandarajah S; Bostad L
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2159-2167. PubMed ID: 27797896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C
    Front Immunol; 2020; 11():607261. PubMed ID: 33613528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
    Front Immunol; 2021; 12():625672. PubMed ID: 33841408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood.
    Noone DG; Twilt M; Hayes WN; Thorner PS; Benseler S; Laxer RM; Parekh RS; Hebert D
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1684-91. PubMed ID: 25147157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood.
    Calatroni M; Consonni F; Allinovi M; Bettiol A; Jawa N; Fiasella S; Curi D; Abu Rumeileh S; Tomei L; Fortunato L; Gelain E; Gianfreda D; Oliva E; Jeannin G; Salviani C; Emmi G; Bodria M; Sinico RA; Moroni G; Ramirez GA; Bozzolo E; Tombetti E; Monti S; Bracaglia C; Marucci G; Pastore S; Esposito P; Catanoso MG; Crapella B; Montini G; Roperto R; Materassi M; Rossi GM; Badalamenti S; Yeung RSM; Romagnani P; Ghiggeri GM; Noone D; Vaglio A
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1043-1051. PubMed ID: 34039568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.
    Lee T; Gasim A; Derebail VK; Chung Y; McGregor JG; Lionaki S; Poulton CJ; Hogan SL; Jennette JC; Falk RJ; Nachman PH
    Clin J Am Soc Nephrol; 2014 May; 9(5):905-13. PubMed ID: 24578329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis.
    van Daalen EE; Wester Trejo MAC; Göçeroğlu A; Ferrario F; Joh K; Noël LH; Ogawa Y; Wilhelmus S; Ball MJ; Honsova E; Hruskova Z; Kain R; Kimura T; Kollar M; Kronbichler A; Lindhard K; Puéchal X; Salvatore S; Szpirt W; Takizawa H; Tesar V; Berden AE; Dekkers OM; Hagen EC; Oosting J; Rahmattulla C; Wolterbeek R; Bos WJ; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1103-1111. PubMed ID: 32723805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the 2010 histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a Bayesian network meta-analysis.
    Huang S; Shen Q; Yang R; Lai H; Zhang J
    Int Urol Nephrol; 2018 Oct; 50(10):1853-1861. PubMed ID: 30046964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
    Chen SF; Wang H; Huang YM; Li ZY; Wang SX; Yu F; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2015 May; 10(5):750-8. PubMed ID: 25749534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty years of experience with anti-neutrophil cytoplasmic antibody glomerulonephritis in Charles Nicolle Hospital-Tunisia: a retrospective cohort study.
    Hajji M; Barbouch S; Goucha R; Hamida FB; Gorsane I; Abderrahim E
    Pan Afr Med J; 2022; 42():84. PubMed ID: 36034042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified histopathological classification with age-related glomerulosclerosis for predicting kidney survival in ANCA-associated glomerulonephritis.
    Aydın MF; Yıldız A; Oruç A; Aytaç Vuruşkan B; Akgür S; Ayar Y; Güllülü M; Dilek K; Yavuz M; Ortaç H; Ersoy A
    Int Urol Nephrol; 2023 Mar; 55(3):741-748. PubMed ID: 36153782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.
    van Daalen EE; Jennette JC; McAdoo SP; Pusey CD; Alba MA; Poulton CJ; Wolterbeek R; Nguyen TQ; Goldschmeding R; Alchi B; Griffiths M; de Zoysa JR; Vincent B; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):63-72. PubMed ID: 29162595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature.
    Moroni G; Binda V; Leoni A; Raffiotta F; Quaglini S; Banfi G; Messa P
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-56-63. PubMed ID: 26016751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis.
    Quintana LF; Peréz NS; De Sousa E; Rodas LM; Griffiths MH; Solé M; Jayne D
    Nephrol Dial Transplant; 2014 Sep; 29(9):1764-9. PubMed ID: 24748668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
    Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
    J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.
    McAdoo SP; Tanna A; Randone O; Tam FW; Tarzi RM; Levy JB; Griffith M; Lightstone L; Cook HT; Cairns T; Pusey CD
    Rheumatology (Oxford); 2015 Jun; 54(6):1025-32. PubMed ID: 25431483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.